When did X4 PHARMACEUTICALS INC (XFOR) report earnings last quarter?
X4 PHARMACEUTICALS INC (XFOR) last reported earnings on 3/17/2026.
X4 PHARMACEUTICALS INC (XFOR) Earnings History & Surprises
NASDAQ:XFOR • US98420X2027
Current stock price
4.13 USD
+0.14 (+3.51%)
At close:
4.21 USD
+0.08 (+1.94%)
After Hours:
XFOR Earnings overview
Past quarterly earnings results for X4 PHARMACEUTICALS INC (XFOR), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Apr 29, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.20
- Revenue Estimate
- 3.264M
Last Reported
Most Recent- Release Date
- Mar 17, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.22
- EPS Surprise
- 37.93%
- Revenue Surprise
- 45.25%
Beat Rate
Last 8 Quarters 25%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.22 | -0.35 | 37.93% | 96.33% | 2.568M | 1.768M | 45.25% | 79.08% |
| Q3 2025 | -0.69 | -0.93 | 26.15% | 87.22% | 1.765M | 2.083M | -15.27% | 215.18% |
| Q2 2025 | -3.47 | -4.42 | 21.58% | -65.24% | 1.973M | 1.644M | 20.01% | 250.44% |
| Q1 2025 | 0.04 | -4.53 | 100.88% | 100.51% | 28.807M | 2.038M | 1,313.49% | - |
| Q4 2024 | -6.00 | -5.36 | -12.04% | -100.00% | 1.434M | 1.062M | 35.03% | - |
| Q3 2024 | -5.40 | -5.29 | -2.09% | -1,700.00% | 560K | 1.727M | -67.57% | - |
| Q2 2024 | -2.10 | 0.17 | -1,301.88% | 78.79% | 563K | 284.243K | 98.07% | - |
| Q1 2024 | -7.80 | -4.98 | -56.52% | -62.50% | - | - | ||
| Q4 2023 | -3.00 | -4.68 | 35.86% | 65.52% | - | - | ||
| Q3 2023 | -0.30 | -4.56 | 93.42% | 96.15% | - | - | ||
| Q2 2023 | -9.90 | -5.00 | -98.08% | 45.00% | - | - | ||
| Q1 2023 | -4.80 | -6.64 | 27.76% | 77.78% | - | - | ||
| Q4 2022 | -8.70 | -7.38 | -17.85% | 67.78% | - | - | ||
| Q3 2022 | -7.80 | -9.16 | 14.81% | 65.79% | - | - | ||
| Q2 2022 | -18.00 | -19.54 | 7.88% | 18.92% | - | - | ||
| Q1 2022 | -21.60 | -18.62 | -15.99% | 44.62% | 123.859K | -100.00% | - | |
| Q4 2021 | -27.00 | -20.90 | -29.21% | 1.10% | - | - | ||
| Q3 2021 | -22.80 | -22.11 | -3.13% | -2.70% | - | - | ||
| Q2 2021 | -22.20 | -22.61 | 1.79% | 2.63% | - | - | ||
| Q1 2021 | -39.00 | -26.28 | -48.42% | -132.14% | - | -100.00% | ||
| Q4 2020 | -27.30 | -27.63 | 1.20% | - | - | - | ||
| Q3 2020 | -22.20 | -23.12 | 3.99% | - | - | - | ||
| Q2 2020 | -22.80 | -21.95 | -3.88% | - | - | - | ||
| Q1 2020 | -16.80 | -24.40 | 31.15% | - | 3M | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
46.64%
Max EPS beat (4)
100.88%
Min EPS beat (4)
21.58%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
340.87%
Max Revenue beat (4)
1,313.49%
Min Revenue beat (4)
-15.27%
Analysis
In the last 4 quarters, XFOR has consistently beaten EPS estimates in all releases
XFOR has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, XFOR has beaten the EPS estimates by 46.6% on average.
In the last 4 quarters, XFOR has beaten the revenue estimates by 340.9% on average.
Related analysis
X4 PHARMACEUTICALS INC / XFOR Earnings FAQ
Did XFOR stock beat earnings estimates in the most recent quarter?
X4 PHARMACEUTICALS INC (XFOR) beat EPS estimates and beat revenue estimates in the most recent quarter.
How often does X4 PHARMACEUTICALS INC (XFOR) beat earnings estimates?
In the last 4 quarters, X4 PHARMACEUTICALS INC (XFOR) has beaten EPS estimates in 4 out of 4 releases.